Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Exploring the Implications of Small-Area Variation in the Incidence of Multiple Sclerosis.
An investigation of commonly prescribed stretches of the ankle plantarflexors in people with Multiple Sclerosis.
Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.
Multiple sclerosis: Single mutation associated with familial progressive MS.
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China.
Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes.
Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
[Improving the sexual quality of life of people with multiple sclerosis].
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis.
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.
Engineering Biomaterials to Influence Oligodendroglial Growth, Maturation, and Myelin Production.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.

Pages